Loading
Latest filing published 22 Feb 2021 for FSD Pharma Inc., €65k.
No signal scores available.
Stephen Earle Buyer discloses dealings in FSD Pharma Inc. to SEDI. Over a trading history stretching from 11 October 2019 to 17 February 2021, the count stands at 4 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
On 22 February 2021 came the latest disclosure, a share grant for €65k in FSD Pharma Inc. Between a trade and the moment it shows up on SEDI, the median delay is 23 days. That lag is the time during which only the insider knows about the trade. Source: insider filings from SEDI. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Same trade as the filing by Robert Joseph Ciaruffoli, counted once
4 of 3 declarations